| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2021 | DGX Quest Diagnostics Inc | Prevoznik Michael E52 | SVP &General Counsel | Sell | 1,188 | $116.95 | $138,936.60 | -1.4% | - | - | |
| Feb 23, 2021 | AMN Amn Healthcare Services Inc | Salka Susan R60 | Chief Executive Officer | Sell | 2,726 | $73.11 | $199,285.32 | -9.8% | - | - | |
| Feb 23, 2021 | PGNY Progyny, Inc. | Bealer Jennifer76 | EVP, General Counsel | Sell | 2,472 | $49.76 | $123,006.72 | -3.3% | - | - | |
| Feb 23, 2021 | HCA Hca Healthcare, Inc. | Englebright Jane D.62 | SVP And Chief Nursing Officer | Sell | 5,751 | $174.75 | $1,005,013.77 | -24.5% | - | - | |
| Feb 23, 2021 | NVOS Novo Integrated Sciences, Inc. | Oliva Robert Letterio | - | Buy | 9,555 | $4.31 | $41,210.05 | +2.5% | - | - | |
| Feb 23, 2021 | HUM Humana Inc | Diamond Susan M54 | Segment President, Home Bus. | Sell | 1,580 | $376.02 | $594,115.23 | -42.0% | +17.2% | +10.1% | |
| Feb 23, 2021 | HUM Humana Inc | Broussard Bruce D53 | President &CEO | Sell | 27,537 | $378.14 | $10,412,717.26 | -29.8% | +17.2% | +10.1% | |
| Feb 23, 2021 | HUM Humana Inc | Fleming William Kevin48 | Seg Pres, Clin &Phm Solutions | Sell | 4,378 | $378.26 | $1,656,043.73 | -42.3% | +17.2% | +10.1% | |
| Feb 22, 2021 | ENSG Ensign Group, Inc | Daniels Lee A67 | Director | Sell | 983 | $82.62 | $81,215.46 | -2.2% | - | - | |
| Feb 22, 2021 | AMN Amn Healthcare Services Inc | Jackson Denise L73 | Chief Legal Officer | Sell | 1,400 | $74.67 | $104,543.74 | -6.9% | - | - | |
| Feb 22, 2021 | MOH Molina Healthcare, Inc. | Romney Ronna60 | Director | Sell | 375 | $219.44 | $82,290.00 | -2.0% | - | - | |
| Feb 22, 2021 | HUM Humana Inc | Huval Timothy S.55 | Chief Administrative Officer | Sell | 3,696 | $377.96 | $1,396,925.01 | -34.5% | +16.8% | +11.4% | |
| Feb 19, 2021 | HCA Hca Healthcare, Inc. | Berres Jennifer | SVP &Chief Human Res. Officer | Sell | 6,692 | $176.05 | $1,178,126.60 | -66.4% | - | - | |
| Feb 19, 2021 | HCA Hca Healthcare, Inc. | Wyatt Christopher F.48 | SVP &Controller | Sell | 3,200 | $177.06 | $566,579.52 | -10.2% | - | - | |
| Feb 18, 2021 | HSIC Henry Schein Inc | Ali Mohamad | Director | Buy | 1,000 | $63.65 | $63,654.00 | New | - | - | |
| Feb 18, 2021 | UNH Unitedhealth Group Inc | Burke Richard T | Director | Sell | 5,000 | $327.60 | $1,637,995.13 | -0.1% | +25.1% | +44.5% | |
| Feb 18, 2021 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 10,000 | $49.08 | $490,820.36 | -0.6% | - | - | |
| Feb 18, 2021 | LH Labcorp Holdings Inc. | Wilkinson Peter J | SVP, Chief Accounting Officer | Sell | 2,317 | $241.51 | $559,589.33 | -87.1% | - | - | |
| Feb 17, 2021 | CVS Cvs Health Corp | Ludwig Edward J60 | Director | Buy | 3,000 | $72.00 | $216,000.00 | +26.5% | +22.7% | +44.1% | |
| Feb 16, 2021 | MCK McKesson Corp | Tyler Brian S. | Chief Executive Officer | Sell | 5,510 | $183.38 | $1,010,423.80 | -22.5% | +10.5% | +54.0% | |
| Feb 16, 2021 | PGNY Progyny, Inc. | Greenbaum Lisa | EVP, Chief Client Officer | Sell | 3,046 | $51.00 | $155,346.00 | -37.7% | - | - | |
| Feb 16, 2021 | UNH Unitedhealth Group Inc | Roos Thomas E47 | Chief Accounting Officer | Sell | 864 | $327.36 | $282,839.04 | -2.8% | +26.3% | +50.0% | |
| Feb 16, 2021 | ACH Accendra Health Inc/va/ | Neal Shana Carol49 | Chief Human Resources Officer | Sell | 4,791 | $27.54 | $131,944.14 | -2.9% | - | - | |
| Feb 16, 2021 | LH Labcorp Holdings Inc. | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sell | 208 | $236.55 | $49,201.63 | -1.5% | - | - | |
| Feb 16, 2021 | LH Labcorp Holdings Inc. | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 188 | $237.06 | $44,567.28 | -2.1% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.